Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03727620Phase 2Completed
Phase 2, randomised, open-label trial of doxycycline in Aggressive Periodontitis (AP) (2 arms), sponsored by Mohammed V University. Primary endpoint: Decrease of periodontal pockets ≥ 4mm. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03727620.